Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 286-302
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286
Figure 3 Expression of cancerous inhibitor of protein phosphatase 2A in human gastric cancer cells.
A: The mRNA expression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human gastric cancer cell lines (MKN-45 and AGS) and normal gastric epithelial cells (GES-1); B: The expression of cancerous inhibitor of protein phosphatase 2A was examined via immunoblotting; C: Immunoblotting was quantified using a spectrophotometer. The results consisted of three independent tests. Gastric cancer cell lines vs GES-1. bP < 0.01. RT: Reverse transcription.
- Citation: Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2023; 15(2): 286-302
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/286.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.286